Detalhe da pesquisa
1.
Temporal profile of serum neurofilament light in multiple sclerosis: Implications for patient monitoring.
Mult Scler
; 27(10): 1497-1505, 2021 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-33307998
2.
Neurofilament light levels are associated with long-term outcomes in multiple sclerosis.
Mult Scler
; 26(13): 1691-1699, 2020 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-31680621
3.
Symbol Digit Modalities Test: A valid clinical trial endpoint for measuring cognition in multiple sclerosis.
Mult Scler
; 25(13): 1781-1790, 2019 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-30334474
4.
The MSOAC approach to developing performance outcomes to measure and monitor multiple sclerosis disability.
Mult Scler
; 24(11): 1469-1484, 2018 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-28799444
5.
Validity of the Symbol Digit Modalities Test as a cognition performance outcome measure for multiple sclerosis.
Mult Scler
; 23(5): 721-733, 2017 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-28206827
6.
The Nine-Hole Peg Test as a manual dexterity performance measure for multiple sclerosis.
Mult Scler
; 23(5): 711-720, 2017 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-28206826
7.
Validity of the timed 25-foot walk as an ambulatory performance outcome measure for multiple sclerosis.
Mult Scler
; 23(5): 704-710, 2017 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-28206828
8.
Validity of low-contrast letter acuity as a visual performance outcome measure for multiple sclerosis.
Mult Scler
; 23(5): 734-747, 2017 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-28206829
9.
Processing speed test: Validation of a self-administered, iPad®-based tool for screening cognitive dysfunction in a clinic setting.
Mult Scler
; 23(14): 1929-1937, 2017 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-28080262
10.
Factors associated with clinically significant increased walking time in multiple sclerosis: results of a survival analysis of short-term follow-up data from a clinical database.
Mult Scler
; 21(4): 457-65, 2015 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-25112816
11.
Experience with fingolimod in clinical practice.
Int J Neurosci
; 125(9): 678-85, 2015.
Artigo
em Inglês
| MEDLINE | ID: mdl-25271798
12.
Predictors of long-term outcome in multiple sclerosis patients treated with interferon ß.
Ann Neurol
; 73(1): 95-103, 2013 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-23378325
13.
Multiple Sclerosis Outcome Assessments Consortium: Genesis and initial project plan.
Mult Scler
; 20(1): 12-7, 2014 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-24057430
14.
The role of cell type-specific responses in IFN-ß therapy of multiple sclerosis.
Proc Natl Acad Sci U S A
; 108(49): 19689-94, 2011 Dec 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-22106296
15.
Temporal Relationship Between Serum Neurofilament Light Chain and Radiologic Disease Activity in Patients With Multiple Sclerosis.
Neurology
; 102(9): e209357, 2024 May 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-38648580
16.
Magnetic resonance fingerprinting in multiple sclerosis.
Mult Scler Relat Disord
; 79: 105024, 2023 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-37783196
17.
Serum neurofilament light-chain levels and long-term treatment outcomes in relapsing-remitting multiple sclerosis patients: A post hoc analysis of the randomized CombiRx trial.
Mult Scler J Exp Transl Clin
; 9(2): 20552173231169463, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37139460
18.
Associations of sNfL with clinico-radiological measures in a large MS population.
Ann Clin Transl Neurol
; 10(1): 84-97, 2023 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36427295
19.
Epsilon toxin-producing Clostridium perfringens colonize the multiple sclerosis gut microbiome overcoming CNS immune privilege.
J Clin Invest
; 133(9)2023 05 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36853799
20.
Beta-interferon for multiple sclerosis.
Exp Cell Res
; 317(9): 1301-11, 2011 May 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-21396360